X0306 4 2022-02-01 false 0001271214 Intersect ENT, Inc. XENT 0001620705 West Thomas A. C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 true true false false President and CEO Common Stock 2022-02-01 4 A false 106540.00 0.00 A 364334.00 D Common Stock 2022-02-02 4 F false 7763.00 27.3064 D 356571.00 D Common Stock 2022-02-04 4 F false 4823.00 27.2762 D 351748.00 D Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the Vesting Commencement Date of February 1, 2022. Includes 500 shares purchased on 11/15/21 with ESPP plan and 281,359 restricted stock units, of which 39,700 are performance based. Shares tendered in payment of the tax withholding obligation in compliance and as required by the company's equity documents. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.20 to $27.55, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Includes 260,526 restricted stock units, of which 39,700 are performance based. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.23 to $27.33, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Includes 247,292 restricted stock units, of which 39,700 are performance based. /s/ Patrick A. Broderick, Attorney-in-Fact for Thomas A. West 2022-02-04